BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4813648)

  • 1. Pulmonary function in Duchenne muscular dystrophy related to stage of disease.
    Inkley SR; Oldenburg FC; Vignos PJ
    Am J Med; 1974 Mar; 56(3):297-306. PubMed ID: 4813648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muscular dystrophy and its problems].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and histopathological studies of the carrier state in Duchenne's muscular dystrophy.
    Ionasescu V; Vuia O; Luca N; Popa P
    Confin Neurol; 1968; 30(5):289-300. PubMed ID: 4891427
    [No Abstract]   [Full Text] [Related]  

  • 4. Coenzyme O in Duchenne muscular dystrophy. A preliminary therapeutic trial.
    Sövik O; Strömme JH; Folkers K
    Acta Paediatr Scand; 1971 Jul; 60(4):428-32. PubMed ID: 5556384
    [No Abstract]   [Full Text] [Related]  

  • 5. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Membrane effects of insulin in x-chromosome recessive hereditary progressive muscular dystrophy (Duchenne form)].
    Blietz R; Kruchten J; Riedl K; Wagner J
    Hoppe Seylers Z Physiol Chem; 1967 Dec; 348(12):1609-15. PubMed ID: 5586908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD)].
    Diotallevi P; Balducci E; Canapa A; Danni M; Giamagli CA; Lucesoli S; Ravaglia P; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):531-8. PubMed ID: 3190906
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary function during clinical remission of asthma. How reversible is asthma?
    Cade JF; Pain MC
    Aust N Z J Med; 1973 Dec; 3(6):545-51. PubMed ID: 4522690
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of breathing in Duchenne's muscular dystrophy.
    Bégin R; Bureau MA; Lupien L; Lemieux B
    Am J Med; 1980 Aug; 69(2):227-34. PubMed ID: 6773416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Duchenne muscular dystrophy: classification of the respiratory failure and study on the prognosis in the terminal stage based on arterial CO2 pressure].
    Motomura M; Kanazawa H; Shibuya N
    Rinsho Shinkeigaku; 1988 Sep; 28(9):992-5. PubMed ID: 3149921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary function in progressive muscular dystrophy.
    Hapke EJ; Meek JC; Jacobs J
    Chest; 1972 Jan; 61(1):41-7. PubMed ID: 5049500
    [No Abstract]   [Full Text] [Related]  

  • 15. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the increase of aldolase in blood in muscular dystrophy].
    GENTILI C
    Clin Pediatr (Bologna); 1959 Sep; 41():736-9. PubMed ID: 13827330
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aldolase activity of the blood in patients with progressive muscular dystrophy].
    BERGAMI PL; ZANOLI S
    Chir Organi Mov; 1959; 47():430-4. PubMed ID: 13799247
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of the creatine coefficient in progressive muscular dystrophy, duchenne type].
    Kominek-Zalewska M; Czyzewski K; Borkowska J
    Neurol Neurochir Pol; 1982; 16(1-3):49-53. PubMed ID: 7133290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.